New hope for advanced liver cancer: experimental drug TTI-101 enters Mid-Stage trials
Disease control
Recruiting now
This study tests a new oral drug called TTI-101 in people with advanced liver cancer that cannot be removed by surgery. The drug is given alone or combined with standard immunotherapy drugs. The main goals are to check safety and see if the drug shrinks tumors. About 193 adults w…
Phase: PHASE1, PHASE2 • Sponsor: Tvardi Therapeutics, Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC